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Abstract
Anorectal melanoma is a rare malignant tumor with a poor prognosis. However, several stud-
ies have reported cases of long-term survival. In this report, we present a patient with anorectal
melanoma who has survived for 9 years after endoscopic mucosal resection. An 85-year-old man
was referred to our hospital for further examination and treatment of an anal tumor 2cm in size.
Endoscopic ultrasonography revealed that the depth of tumor invasion was confined to the sub-
mucosal layer. Endoscopic mucosal resection was performed, and the tumor was diagnosed as a
malignant melanoma. The patient was followed without any additional treatment, which was per
his wishes. Although melanoma recurred 4 times thereafter, endoscopic mucosal resection was
performed for each recurrent lesion. Thus, he has been alive for 9 years since the first endoscopic
mucosal resection without distant metastases. If the depth of tumor invasion is shallow, endoscopic
mucosal resection is a useful option among other therapeutic modalities.
KEYWORDS: malignant melanoma, anorectum, endoscopic mucosal resection (EMR), long-
term survival
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Anorectal melanoma is a rare malignant tumor with a poor prognosis.  However,  several studies have 
reported cases of long-term survival.  In this report,  we present a patient with anorectal melanoma 
who has survived for 9 years after endoscopic mucosal resection.  An 85ﾝyear-old man was referred to 
our hospital for further examination and treatment of an anal tumor 2cm in size.  Endoscopic ultraso-
nography revealed that the depth of tumor invasion was conﬁned to the submucosal layer.  Endoscopic 
mucosal resection was performed,  and the tumor was diagnosed as a malignant melanoma.  The 
patient was followed without any additional treatment,  which was per his wishes.  Although melanoma 
recurred 4 times thereafter,  endoscopic mucosal resection was performed for each recurrent lesion.  
Thus,  he has been alive for 9 years since the ﬁrst endoscopic mucosal resection without distant metas-
tases.  If the depth of tumor invasion is shallow,  endoscopic mucosal resection is a useful option among 
other therapeutic modalities.
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n the gastrointestinal (GI) tract,  the anorectum 
is a site at which malignant melanoma arises 
frequently.  Anorectal malignant melanoma has been 
shown to result in worse prognoses than cutaneous 
melanoma [1].  However,  several studies [2ﾝ4] have 
reported cases of long-term survival when treatment 
consisted only of local surgical excision.  We herein 
present the case of a patient with anorectal malignant 
melanoma treated by endoscopic mucosal resection 
(EMR) alone.  He has survived for 9 years without 
distant metastases.
Case Report
　 An 85ﾝyear-old man visited an outside hospital 
with a chief complaint of anal bleeding in July 1999.  
He underwent colonoscopy and an anal tumor was 
found.  He was admitted to our hospital for further 
examination and treatment.  His past medical history 
was signiﬁcant and included sigmoidectomy in 1986 for 
sigmoid colon cancer.  Physical examination and rou-
tine blood tests revealed no major abnormalities.  
Barium enema showed a nodular tumor about 2cm in 
size in the rectum adjacent to the anal verge (Fig.  
1A).  Colonoscopic examination revealed a dark and 
nodular polypoid lesion about 2cm in size,  which was 
1cm above the anal verge (Fig.  1B).  The tumor had a 
smooth surface,  and there was no evidence of erosion 
or ulceration.  A 20-MHz ultrasound catheter probe 
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revealed a hypoechoic mass,  and indicated that the 
lesion was nearly conﬁned to the submucosal layer 
(Fig.  1C).  Whole body computed tomography and 
upper GI endoscopy did not reveal any other abnor-
malities.
　 The endoscopic biopsy specimen revealed a round 
cell tumor,  but a deﬁnitive diagnosis was not made.  
Therefore,  EMR was performed to not only control 
the bleeding,  but also to make a deﬁnitive diagnosis.  
The resection specimen,  measuring 22×18mm,  
showed a black solid tumor that was covered with 
normal mucosa in a cut surface view (Fig.  2A).  
Microscopic ﬁndings revealed diﬀuse inﬁltration of 
round or spindle-shaped tumor cells that contained 
melanin in the submucosal layer (Fig.  2B).  Immuno-
histochemically,  tumor cells were positive for Human 
Melanin Black-45 (HMB-45) (Fig.  2C).  The ﬁnal 
diagnosis was a primary anorectal malignant melanoma 
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Fig. 1　 A,  Barium enema image showing a nodular tumor about 2cm in size in the rectum adjacent to the anal verge (arrows); B,  
Colonoscopic view of lesion,  demonstrating a dark and nodular polypoid lesion about 2cm in size at 1cm above the anal verge; C,  EUS 
image showing the lesion as a hypoechoic mass,  indicating it is almost conﬁned to the submucosal layer.  Arrows indicate the submucosal 
layer.
Ａ Ｂ Ｃ
Fig. 2　 A,  A cut surface view of the resection specimen,  measuring 22×18mm,  showing a black solid tumor covered with normal 
mucosa; B,  Photomicrograph of resection specimen showing diﬀuse inﬁltration of round or spindle-shaped tumor cells containing melanin 
(arrows) in the submucosal layer (Hematoxylin and Eosin staining,×300); C,  Immunohistochemically,  tumor cells were positive for 
HMB-45 (HMB-45 staining,×400).
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based on these histopathological features.  Tumor cells 
were not seen in the resected margin.  However,  both 
lymphatic and venous invasion were noted.  The patient 
was followed without any additional treatment,  
because the patient and his family refused additional 
treatment.
　 Local recurrence was conﬁrmed at the same site 1 
year and 10 months after EMR.  The recurrent tumor,  
3×4cm in size,  was larger than the ﬁrst tumor.  
EMR was performed for the recurrent tumor because 
the patient and his family refused other options.  The 
resection specimen was histopathologically similar to 
the ﬁrst tumor.
　 Moreover,  3 years and 2 months after the ﬁrst 
EMR,  melanoma recurred at the site adjacent to the 
ﬁrst tumor.  This tumor was 1.5cm in size,  and EMR 
was performed.  To date there have been 2 more local 
recurrences,  but EMR was performed for each lesion.  
The patient remains well without distant metastases.
Discussion
　 The GI tract is the third most common site of 
occurrence of malignant melanoma,  after the skin and 
eyes [3].  In the GI tract,  the anorectum is a site at 
which malignant melanoma arises frequently,  because 
of the presence of abundant melanocytes in the mucosa 
of the anal canal [5].  However,  anorectal malignant 
melanoma is a rare disease,  since melanoma accounts 
for less than 1ｵ of primary anorectal malignancies 
[6].
　 Anorectal malignant melanoma is thought to have a 
poor prognosis because it is often misdiagnosed for 
hemorrhoids,  which causes a delay in making the cor-
rect diagnosis [1,  3].  Overall,  the 5ﾝyear survival 
rate is reported to be 10ｵ or less even if radical 
surgery (abdominoperineal resection) and chemother-
apy are performed [6].
　 However,  several studies have reported cases of 
long-term survival.  For example,  Malik et al.  [3] 
reported the case of a patient with a 5.75-mm thick 
anorectal melanoma who survived for 10 years after 
wide local excision.  Whooley et al.  [7] reported a 5ﾝ
year survivor after abdominoperineal resection and 
chemotherapy for a 2.5-mm thick anorectal melanoma.  
It has been shown that an important determinant of 
prognosis for any primary melanoma is the tumor 
thickness.  Speciﬁcally,  “thin” anorectal melanomas 
(＜1mm) have a more favorable prognosis than thicker 
anorectal melanomas [8,  9].  However,  there are 
cases of long-term survival in spite of the presence of 
thick lesions (＞4mm) or lesions of intermediate thick-
ness (1ﾝ4mm).  With regard to cutaneous melanomas,  
Clark et al.  [10] reported that the invasive radial 
growth phase of melanoma is indolent and incapable of 
metastasis.  Histologically,  it is characterized by scat-
tered foci of papillary dermal invasion that are only 
comprised of scattered cells or small clusters,  and 
with only rare mitotic ﬁgures.  Whooley et al.  [7] 
proposed that these histological ﬁndings might also be 
related to the prognosis for anorectal melanoma.  In 
the present case,  it is possible that this tumor pos-
sessed the histological feature of being incapable of 
metastasis in addition to a small volume of tumor 
cells.
　 In Japan,  approximately 15 cases of survival longer 
than 5 years have been reported [11,  12].  According 
to an analysis of these long-term survivors,  the condi-
tions for longer survival were a tumor diameter of less 
than 5cm and a tumor depth of invasion conﬁned to the 
muscularis propria.
　 EMR for primary malignant melanoma in the GI 
tract has been performed in only 5 cases [2,  13ﾝ15] 
including ours.  These cases are summarized in Table 
1.  Relatively long-term survival was achieved in most 
cases.  Among these cases,  only our case involved no 
additional treatment after EMR.
　 In the present case,  local recurrence has occurred 
four times so far.  EMR was performed for each 
recurrent lesion.  The patient is alive with no evidence 
of distant metastases even though 9 years have passed 
since the ﬁrst EMR.  Endoscopic ultrasonography 
(EUS) for the ﬁrst lesion conﬁrmed that tumor inva-
sion was conﬁned to the submucosa.  Examination of 
the specimen resected by EMR conﬁrmed the negative 
margins.  Therefore,  this case is thought to have met 
the conditions for long-term survival.  However,  in the 
future,  close follow-up for local recurrence including 
distant metastases is necessary.
　 Long-term survival is expected,  even if less inva-
sive surgery such as EMR is performed,  in cases of 
anorectal melanoma in which a shallow depth of inva-
sion is conﬁrmed by EUS.  Thus,  the staging system 
and selection of therapeutic modalities should be based 
on tumor size and depth of invasion.
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Table 1　 Reported cases in which EMR was performed for primary malignant melanoma in the GI tract
No. Authors
(year)
Age/Sex Location Size
(mm)
Depth Additional
treatment
Prognosis
1 Herman
et al. [13]
(2001)
55/M Esophagus 50 － IFN§ therapy 25 months
2 Nishina
et al. [2]
(2001)
76/M Anorectum 10 M† Local excision 8 years
3 Fukui
et al. [14]
(2002)
54/F Anorectum 6 － APR¶
＋chemotherapy
More than
6 years
4 Hirose
et al. [15]
(2002)
57/M Esophagus 33 SM‡ Irradiation 12 months
5 Our
case
(2008)
85/M Anorectum 22×18 SM　 None 9 years
†M,  invasion conﬁned to the mucosal layer;
‡SM,  invasion conﬁned to the submucosal layer;
§IFN,  interferon;
¶APR,  abdominoperineal resection.
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